Orange Book product · Generic (ANDA)
PROGESTERONE
PROGESTERONE
At a glance
Nov 21, 2023
Approved
Generic (ANDA)
Application
Not listed
TE code
None
Listed patents
Key dates
Approval
FDA approval date of this drug product.
Nov 21, 2023
2 yr 7 mo ago
Today
Pharmaceutical detail
Active ingredient
PROGESTERONE
Strength
50MG/ML
Dosage form
INJECTABLE
Route
INJECTION
TE code
Not listed
Application
ANDA 217707
Product number
001
Marketing status
DISCN
Reference listed drug (RLD)
No
Reference standard (RS)
No
Active-ingredient family
View full familyGeneric (ANDA) of PROGESTERONE
- 2020MILPROSABrand (NDA)
NDA 201110 · FERRING PHARMS INC
- 2007ENDOMETRINBrand (NDA)
NDA 022057 · FERRING
- 1998PROMETRIUMBrand (NDA)
NDA 019781 · ACERTIS PHARMS
- 1997CRINONEBrand (NDA)
NDA 020701 · ABBVIE
- —PROGESTERONEBrand (NDA)
NDA 017362 · ACTAVIS LABS UT INC
- —PROGESTERONEBrand (NDA)
NDA 009238 · LILLY
- —PROGESTASERTBrand (NDA)
NDA 017553 · ALZA
- 2026PROGESTERONEGeneric (ANDA)
ANDA 216363 · GLENMARK PHARMS
- 2025PROGESTERONEGeneric (ANDA)
ANDA 218391 · XIROMED
- 2022PROGESTERONEGeneric (ANDA)
ANDA 215634 · XIROMED
- 2018PROGESTERONEGeneric (ANDA)
ANDA 210965 · EUGIA PHARMA
- 2018PROGESTERONEGeneric (ANDA)
ANDA 211285 · EUGIA PHARMA
Listed patents
No patents are listed against this product in the Orange Book. Listed patents reflect those the NDA holder submits under 21 U.S.C. 355 and are not exhaustive.
